Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAMS

Compositions for Modification of Genomic DNA and Exogenous Gene Expression and Related Applications

  • Read more about Compositions for Modification of Genomic DNA and Exogenous Gene Expression and Related Applications
US Application 61/905,002
Filed on 2013-11-15

TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes

  • Read more about TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes
US Application 61/474,351
Filed on 2011-04-12

Blockade of TL1A-DR3 Interactions To Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof

  • Read more about Blockade of TL1A-DR3 Interactions To Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof
US Application 61/488,671
Filed on 2011-05-20

Generation And Use Fab, SCFV, And Related Binding Molecules Specific For HIV-1 Rev

  • Read more about Generation And Use Fab, SCFV, And Related Binding Molecules Specific For HIV-1 Rev
US Application 61/439,307
Filed on 2011-02-03

A nanofiberous conduit seeded with muscle-derived mesenchymal progenitor cells

  • Read more about A nanofiberous conduit seeded with muscle-derived mesenchymal progenitor cells
US Application 61/117,814
Filed on 2008-11-25

TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes May Indicate Early Signs Of Osteoarthritis

  • Read more about TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes May Indicate Early Signs Of Osteoarthritis
US Application 61/333,479
Filed on 2010-05-11

Disabling autophagy as a treatment for lysosomal storage diseases

  • Read more about Disabling autophagy as a treatment for lysosomal storage diseases
US Application 61/275,984
Filed on 2009-09-04

Blockade Of TL1A-DR3 Interactions To Ameliorate T-Cell Mediated Disease Pathology

  • Read more about Blockade Of TL1A-DR3 Interactions To Ameliorate T-Cell Mediated Disease Pathology
US Application 60/879,668
Filed on 2007-01-10

Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebra Disc.

  • Read more about Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebra Disc.
US Application 60/848,284
Filed on 2006-09-28

Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebral Disc

  • Read more about Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebral Disc
US Application 60/847,839
Filed on 2006-09-27

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAMS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health